Регистрация | Вход в службу | FAQ      [?] 

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders)

Статьи последних нескольких выпусков журнала CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) © Bentham Science Publishers
  • Author Index to Volume 4
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. i-ii.
    by Bentham S Publishers,
  • Subject Index to Volume 4
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. iii-xi.
    by Bentham S Publishers,
  • Editorial [Hot Topic: Dopaminergic Neurotransmission (Guest Editor: Remco H.S. Westerink)]
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 1-1.
    by Westerink, HS Remco
  • Dopamine Receptor Pharmacology: Interactions with Serotonin Receptors and Significance for the Aetiology and Treatment of Schizophrenia
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 3-23.
    by Werkman, , Glennon, , Wadman, , Mccreary,
  • The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 25-43.
    by Sokoloff, , Diaz, , Foll, , Guillin, , Leriche, , Bezard, , Gross,
  • Molecular Biology, Pharmacology and Functional Role of the Plasma Membrane Dopamine Transporter
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 45-56.
    by Sotnikova, D Tatyana, Beaulieu, Jean-Martin, Gainetdinov, R Raul, Caron, G Marc
  • Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 57-77.
    by Westerink, HS Remco
  • Excitability of Dopamine Neurons: Modulation and Physiological Consequences
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 79-97.
    by Marinelli, , Rudick, , Hu, T X-, White,
  • Phasic Dopamine Signaling During Behavior, Reward, and Disease States
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 99-108.
    by Heien, , Wightman,
  • Dopamine and the Diseased Brain
    CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, No. 1. (February 2006), pp. 109-131.
    by Kienast, , Heinz,
  • Editorial [Hot Topic:The Endocannabinoid System in the Brain: From Biology to Therapy (Guest Editor: Mauro Maccarrone)]
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 613-613.
    by Mauro Maccarrone
  • Endocannabinoid Metabolic Pathways and Enzymes
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 615-623.
    by Alessia Ligresti, Maria G Cascio, Vincenzo D Marzo
  • Molecular Biology of the Enzymes that Degrade Endocannabinoids
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 625-631.
    by Robyn A Puffenbarger
  • Endocannabinoids in the Central Nervous System: From Neuronal Networks to Behavior
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 633-642.
    by Ester Fride
  • Endocannabinoids and Drug Dependence
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 643-655.
    by Daniela Parolaro, Daniela Vigano, Tiziana Rubino
  • Endocannabinoids in Neuroimmunology and Stress
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 657-665.
    by Erica J Carrier, Sachin Patel, Cecilia J Hillard
    posted by 1 person txt
  • From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 667-675.
    by Anna M Malfitano, Giuseppe Matarese, Maurizio Bifulco
  • Cannabinoids: Between Neuroprotection and Neurotoxicity
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 677-684.
    by Yosef Sarne, Raphael Mechoulam
  • Pharmacological Properties and Therapeutic Possibilities for Drugs Acting Upon Endocannabinoid Receptors
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 685-696.
    by Christopher J Fowler
  • Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 697-707.
    by Silvia Ortega-Gutierrez
  • Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 6. (December 2005), pp. 709-714.
    by Enrico Dainese, Valeria Gasperi, Mauro Maccarrone
  • Editorial Hot Topic: Cognition Therapeutics (Guest Editor: Miao-Kun Sun)
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 467-467.
    by Miao-Kun Sun
  • Low Density Lipoprotein Receptor-Related Proteins (LRPs), Alzheimer's and Cognition
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 469-480.
    by ME Harris-White, SA Frautschy
  • CREB, Synapses and Memory Disorders: Past Progress and Future Challenges
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 481-497.
    by Sheena A Josselyn, Peter V Nguyen
  • Memantine: A Therapeutic Approach in Treating Alzheimer's and Vascular Dementia
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 499-506.
    by Horst J Koch, Gokhan Uyanik, David Fischer-Barnicol
  • Cannabinoids
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 507-530.
    by Franjo Grotenhermen
  • Increasing Testosterone Levels and Effects on Cognitive Functions in Elderly Men and Women: A Review
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 531-540.
    by E Hogervorst, S Bandelow, SD Moffat
  • Protein Kinase C Isozymes: Memory Therapeutic Potential
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 541-552.
    by Miao-Kun Sun, Daniel L Alkon
  • Cholesterol and Apoe: A Target for Alzheimer's Disease Therapeutics
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 553-567.
    by Daniela Fenili, Joanne Mclaurin
  • Abeta Immunotherapy and Other Means to Remove Amyloid
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 569-573.
    by Edith G Mcgeer, Patrick L Mcgeer
  • Neuroactive Flavonoids Interacting with GABAA Receptor Complex
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 575-585.
    by Feng Wang, Yan, Shui Y Tsang, Hong Xue
  • Small Transthyretin (TTR) Ligands as Possible Therapeutic Agents in TTR Amyloidoses
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 587-596.
    by MR Almeida, L Gales, AM Damas, I Cardoso, MJ Saraiva
  • Neuronal Plasticity, Stress and Depression: Involvement of the Cytoskeletal Microtubular System?
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 5. (October 2005), pp. 597-611.
    by M Bianchi, JJ Hagan, CA Heidbreder
  • Editorial Hot Topic: Neuron-Glia Interaction (Guest Editor: Joao O. Malva)
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 317-317.
    by Joao O Malva
  • Role of Nitric Oxide and Calpain Activation in Neuronal Death and Survival
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 319-324.
    by IM Araujo, CM Carvalho
  • What can Adenosine Neuromodulation do for Neuroprotection?
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 325-329.
    by JA Ribeiro
  • The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 331-347.
    by AP Silva, S Xapelli, E Grouzmann, C Cavadas
  • Inflammation and Neurogenesis in Temporal Lobe Epilepsy
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 349-360.
    by L Bernardino, R Ferreira, AJ Cristovao, F Sales, JO Malva
  • Molecular Targets and Therapeutic Strategies in Huntington's Disease
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 361-381.
    by AC Rego, LP de Almeida
  • Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 383-403.
    by C Pereira, P Agostinho, PI Moreira, SM Cardoso, CR Oliveira
  • Neurodegenerative Pathways in Parkinson's Disease: Therapeutic Strategies
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 405-419.
    by SM Cardoso, PI Moreira, P Agostinho, C Pereira, CR Oliveira
  • Old and New Drug Targets in Diabetic Retinopathy: From Biochemical Changes to Inflammation and Neurodegeneration
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 421-434.
    by EC Leal, AR Santiago, AF Ambrosio
  • Organotypic Hippocampal Slice Cultures for Studies of Brain Damage, Neuroprotection and Neurorepair
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 435-452.
    by J Noraberg, FR Poulsen, M Blaabjerg, BW Kristensen, C Bonde, M Montero, M Meyer, JB Gramsbergen, J Zimmer
  • Liposomal and Viral Vectors for Gene Therapy of the Central Nervous System
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 4. (August 2005), pp. 453-465.
    by de Lima, Girao, Cardoso, S Simoes, LP de Almeida
  • Editorial Hot Topic: Amyloid-Associated Disease Mechanisms in Alzheimer's Disease (Guest Editor: Jeroen J.M. Hoozemans)
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 221-222.
    by Jeroen J Hoozemans
  • The Neuroinflammatory Response in Plaques and Amyloid Angiopathy in Alzheimer's Disease: Therapeutic Implications
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 223-233.
    by Annemieke J Rozemuller, Willem A van Gool, Piet Eikelenboom
  • Amyloid Associated Proteins in Alzheimer's and Prion Disease
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 235-248.
    by R Veerhuis, R Boshuizen, A Familian
  • Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimer's Disease
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 249-266.
    by L- F Lue, S Yan, D Stern, D Walker
  • The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 267-281.
    by Freek L van Muiswinkel, H Kuiperij
  • Protein Quality Control in Alzheimer's Disease: A Fatal Saviour
    Current Drug Targets - CNS & Neurological Disorders, Vol. 4, No. 3. (June 2005), pp. 283-292.
    by W Scheper, E Hol
    • Вы можете ссылаться на эту страницу по адресу: http://www.citeulike.org/journal/ben-cdtcnsnd

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.